How should I treat a misplaced self-expanding aortic bioprosthetic valve?

EuroIntervention

Volumn 6, Issue 4, 2010, Pages

  Majunke, Nicolas ^a   Doss, Mirko ^b   Steinberg, Daniel H ^c   Bargenda, Steffen ^a   Plachky, Jens ^d   Rieck, Benjamin ^e   Wunderlich, Nina ^a   Sievert, Horst ^a  

^a CARDIOVASCULAR CENTER FRANKFURT   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d Ambulantes OP Zentrum   (Germany)

^e Regis Medical   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AORTA PRESSURE; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; BIOPROSTHESIS; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; EQUIPMENT DESIGN; HEART CATHETERIZATION; HEART FAILURE; HEART VENTRICLE OVERLOAD; HOSPITALIZATION; HUMAN; HYPERTENSION; MALE; PROSTHESIS FAILURE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; AORTA VALVE; AORTA VALVE STENOSIS; HEART VALVE REPLACEMENT; METHODOLOGY;

AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; BIOPROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE;

EID: 79952197045     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJ30V6I4A88     Document Type: Article

References (7)

1. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Raimondo A, Ussia G, Wenaweser P, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18F) CoreValve Revalving® system: results from the multicenter, expanded evaluation registry 1 year following CE mark approval. EuroIntervention 2008;4:242-249.
2. Eltchaninoff H, Zajarias A, Tron C, Litzler PY, Baala B, Godin M, Bessou JP, Cribier A. Transcatheter aortic valve implantation: technical aspects, results and indications. Arch Cardiovasc Dis 2008;101:126-132. (Pubitemid 351462744)
3. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76. (Pubitemid 46970878)
4. Piazza N, Schultz C, de Jaegere PPT, Serruys PW. Implantation of two self-expanding aortic bioprosthetic valves during the same procedure - Insights into valve-in-valve implantation (Russian doll concept). Catheter Cardiovasc Interv 2009;73:530-539.
5. Ruiz CE, Laborde JC, Condado JF, Chiam PT, Condado JA. First percutaneous transcatheter aortic valve-in-valve implant with three year follow-up. Catheter Cardiovasc Interv 2008;72:143-148.
6. Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest AM, Anderson RH, de Jaegere P, Serruys PW. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv. 2008;1:310-316. (Pubitemid 351804194)
7. Vavouranakis M, Vrachatis DA, Toutouzas KP, Chrysohoou C, Stefanadis C. "Bail out" procedures for malpositioning of aortic valve prosthesis (CoreValve). Int J Cardiol. 2009;Epub ahead of print.